| LIVZON PHARMAC. GRP H YC1 |
| China |
| Gesundheit |
| CNE100001QV5 / A1XCAW |
| LP6 (Frankfurt) |
| FRA:LP6, ETR:LP6, LP6:GR |
| - |
| https://livzon.com.cn/ |
|
Livzon Pharmaceutical Group Co., Ltd. is a prominent player in the biopharmaceutical industry, focusing on the research, development, production, and distribution of pharmaceuticals. The company's primary function is to manufacture a diverse range of..
>Volltext.. |
| 3533.72 Mio. EUR |
| 2874.18 Mio. EUR |
| 1450.03 Mio. EUR |
| 381.38 Mio. EUR |
| 243.51 Mio. EUR |
| 0.27 EUR |
| 476.65 Mio. EUR |
| 1153.43 Mio. EUR |
| 388.07 Mio. EUR |
| 1.51 |
| -10.49% |
| -13.86% |
| 0.13 EUR |
| 4.41% |
| 6.24% |
| 13.06.25 - 0.13239084€ 08.07.24 - 0.1636754€ >weitere anzeigen... |
| - |
| LIVZON |
| 05.04.26 |
|